Kala Bio Inc (NAS:KALA)
$ 6.72 -0.1375 (-2.01%) Market Cap: 30.98 Mil Enterprise Value: 19.45 Mil PE Ratio: 0 PB Ratio: 4.51 GF Score: 46/100

Kala Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript

Jun 09, 2023 / 03:55PM GMT
Release Date Price: $14.48 (-3.21%)
Chris Howerton
(Trades, Portfolio) LLC - Analyst

Okay. Hi, everybody. Thank you so much for joining us. My name is Chris Howerton, part of the Jefferies biotechnology research team. Very excited to see everybody here at our healthcare conference for the third day. And we are hosting a fireside chat with our next company, Kala Pharmaceuticals.

And on behalf of the company, we have Kim Brazzell, the CMO. Thanks for joining us here.

Kim Brazzell;Chris Howerton
Kala Pharmaceuticals, Inc - Head, R&D & Chief Medical Officer; (

It's great to be here. My colleague, Todd Bazemore couldn't make it because flight got canceled, because of the smoke.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot